Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

573
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
573

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial.

Frontiers in endocrinology·2023
Same author

Global Burden of Cardiovascular Disease from 1990 to 2019 Attributable to Dietary Factors.

The Journal of nutrition·2023
Same author

Progress in the application of patch materials in cardiovascular surgery.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2023
Same author

Purinergic receptor P2X7 contributes to abdominal aortic aneurysm development via modulating macrophage pyroptosis and inflammation.

Translational research : the journal of laboratory and clinical medicine·2023
Same author

Evaluation of the effectiveness and safety of a multi-faceted computerized antimicrobial stewardship intervention in surgical settings: A single-centre cluster-randomized controlled trial.

International journal of antimicrobial agents·2023
Same author

Expression characteristics of Hsd3b7 in the gonads of Paralichthys olivaceus.

Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology·2023

Related Experiment Video

Updated: Dec 17, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

413

A machine learning-based prognostic predictor for stage III colon cancer.

Dan Jiang1,2, Junhua Liao3,4, Haihan Duan3,4

  • 1Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.

Scientific Reports
|June 27, 2020
PubMed
Summary

A new computer-aided model, Gradient Boosting-Colon, predicts stage III colon cancer prognosis using H&E stained slides. This tool stratifies patients into high- and low-risk groups, aiding treatment planning.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

563
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Dec 17, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

413
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

563
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Oncology
  • Computational Pathology
  • Digital Health

Background:

  • Prognostic biomarkers for stage III colon cancer are limited.
  • Accurate prediction of recurrence risk and prognosis is crucial for treatment planning.

Purpose of the Study:

  • To develop and validate a computer-aided approach for predicting prognosis in stage III colon cancer using routine H&E stained tissue slides.

Main Methods:

  • A convolutional neural network combined with a machine classifier was developed.
  • The model, named Gradient Boosting-Colon, was trained on 101 stage III colon cancer cases from West China Hospital (WCH).
  • Model performance was validated using independent cohorts from WCH (67 cases) and The Cancer Genome Atlas Colon Adenocarcinoma database (47 cases).

Main Results:

  • Gradient Boosting-Colon demonstrated significant prognostic value in multivariate Cox proportional hazards analysis.
  • The model identified high-risk recurrence groups with hazard ratios (HR) of 8.976 and 10.273 in the test sets.
  • It also stratified patients into poor and good prognosis groups with HRs of 10.687 and 5.033.

Conclusions:

  • Gradient Boosting-Colon serves as an independent machine prognostic predictor for stage III colon cancer.
  • The model effectively stratifies patients into distinct risk and prognosis groups directly from H&E slides.
  • These findings offer valuable insights for personalized treatment strategies in stage III colon cancer.